Novogene of Beijing Forms Diagnostic Partnership with Illumina

Novogene, a Beijing genomics-diagnostics company, will collaborate with Illumina to develop a user-friendly clinical diagnostic for prenatal DNA and oncology testing in China. The two companies will combine Illumina sequencing technology with Novogene's advanced clinical application expertise. Specifically, Novogene will provide its nucleic acid extraction, library preparation, and data analysis software, while Illumina will provide NGS instrument components and related reagents. More details.... Stock Symbol: (NSDQ: ILMN) Share this with colleagues: // //